Please find the video recording from the January 22, 2021 webinar where Mallinckrodt Pharmaceuticals presented their reasoning behind the discontinuation of the Adrabetadex program.
Please find the video recording from the January 22, 2021 webinar where Mallinckrodt Pharmaceuticals presented their reasoning behind the discontinuation of the Adrabetadex program.